Cite
APA Citation
Meric-Bernstam, F., Arkenau, H., Tran, B., Bahleda, R., Kelley, R., Hierro, C., Ahn, D., Zhu, A., Javle, M., Winkler, R., He, H., Huang, J., & Goyal, L. (n.d.). o-001Efficacy of TAS-120, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in cholangiocarcinoma patients with FGFR pathway alterations who were previously treated with chemotherapy and other FGFR inhibitors. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095516736.0x00003d